NIH-funded research U01 cooperative agreement

Comparing ketamine and morphine for treating acute pain in children.

Official title: Efficacy of intravenous sub-dissociative ketamine versus intravenous morphine in children with acute pain.

Funded at Columbia University Health Sciences · NIH-10990856 · Data updated 2026-11-12

This study is looking at whether a lower dose of ketamine can help kids in the emergency room feel better from pain compared to morphine, with the goal of finding a safer and more effective way to treat their pain.

More Ketamine research and trials

Quick facts

Grant typeU01 cooperative agreement
Study typeNIH-funded research
Funding institutionColumbia University Health Sciences
NIH-funded
Lab location1 site (New York, United States)
Project startSeptember 5, 2024
Project endAugust 31, 2029
Funding year2024
Award (this year)$3,403,269
NIH project number1U01HD116253-01
Project IDNIH-10990856 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are children aged 0 to 17 years experiencing acute pain, particularly those presenting to emergency departments.

Less likely to help

Patients with chronic pain conditions or those who are not experiencing acute pain may not benefit from this research.

What this research studies

This research investigates the effectiveness of intravenous sub-dissociative ketamine compared to intravenous morphine for managing acute pain in children visiting emergency departments. The study aims to address the common issue of inadequate pain treatment in pediatric patients, which can lead to both immediate and long-term consequences. By using sub-dissociative doses of ketamine, the research seeks to provide a safer alternative to morphine, which is often associated with serious side effects. The study will evaluate pain relief outcomes and the potential for reducing long-term complications related to acute pain.

Why it matters

Potential benefit: If successful, this research could provide a safer and more effective pain management option for children in emergency settings.

How similar studies have gone: Previous research has shown that sub-dissociative doses of ketamine can be effective and safe for pain management in adults, suggesting potential success in pediatric applications.

Where this research is happening

  • Columbia University Health Sciences
    New York, United States
    Active

Researchers

  • Principal investigator: Tsze, Daniel Sing-Kwong — Columbia University Health Sciences
  • Study coordinator: Tsze, Daniel Sing-Kwong

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.